跳至主要内容
临床试验/NCT04315454
NCT04315454Unknown1 期

The Analgesic Efficacy of Erector -Spinae Technique With Levobupvicaine in Patients Undergoing Upper Abdominal Cancer Surgery

South Egypt Cancer Institute1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
发起方
入组人数
30
试验地点
1
主要终点
morphine consumption

研究概览

简要总结

To study analgesic efficacy &safety of bilateral erector spinae block for upper abdominal cancer surgery as apart of multimodal analgesia.

详细描述

Patients will be randomly assigned using computer generated randomization program (http://www.randomizer.org) into two groups, each group of the them consist of 15 patients:

GROUP (A): {CONTROL GROUP} Patient will receive 20 ml of normal saline into interfascial plane between rhomboidus major &erector spinae muscle bilaterally at level thoracic spine T7,10 ml each side .

Group (B):

Patient will receive 20 mg 0.25% Levobupivacaine bilaterally as above 10 mg each side.

Preoperatively & post-operatively procedures:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient subjected to major upper abdominal cancer surgery.
  • The enrolled age will be from 18-70 years old.
  • ASA: I-III, NYHA: I-III.

排除标准

  • ASA & physical status (NYHA) > III.
  • Pregnant women.
  • Body mass index >40 kg/m
  • Pre-operative opioid consumption.
  • Contraindication or patient's refusal of the procedure.
  • Un co-operative patient.
  • Coagulopathy, skin infection, significant organ dysfunction or drug allergy.

研究组 & 干预措施

Group A

Placebo Comparator

patients will receive 20 ml of normal saline into interfascial plane between rhomboids major &erector spinae muscle bilaterally at level thoracic spine T7,10 ml each side.

干预措施: Levobupivacaine (Drug)

Group B

Experimental

Patients will receive 20 mg 0.25% Levobupivacaine into the interfascial plane between rhomboids major &erector spinae muscle bilaterally at level thoracic spine T7,10 ml each side.

干预措施: Levobupivacaine (Drug)

结局指标

主要结局

morphine consumption

时间窗: 24 hours

Decrease morphine consumption.

次要结局

  • blood gas(24 hours)
  • Hemodynamic(24 hours)
  • VAS score(24 hours)
  • patient satisfaction(24 hours)

研究者

发起方
South Egypt Cancer Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Romany Gamal Rezk Bakeet

anesthesia specialist

South Egypt Cancer Institute

研究点 (1)

Loading locations...

相似试验